ALSO IN THIS MONTH'S ISSUE

More from this month's issue

BEYOND THE PRINTED PAGE

  • Making A Difference Matters

    Dr. Helen Torley, president and CEO of Halozyme Therapeutics, shares a story of how the biopharmaceutical industry makes a difference.

  • Helen Torley’s Path To The C-Suite

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her path to the c-suite, including the formative experience that best prepared her for becoming a CEO.

  • Could Halozyme’s U.S. Patent 8,846,034 Be Another Royalty Boon?

    Helen Torley, president and CEO of Halozyme Therapeutics, discusses hyaluronan and the role it plays in development of ENHANZE, PEGPH20 along with a staining diagnostic to determine patients with high levels of hyaluronic acid (HA).

More beyond the printed page articles

 EVENTS

Bio CEO & Investor Conference February 11 - 12, 2019
New York, NY
BIO Asia International Conference March 5 - 6, 2019
Tokyo
26th International Molecular Medicine Tri-Conference March 10 - 15, 2019
San Francisco, CA
INTERPHEX April 2 - 4, 2019
New York, NY
More events....

JANUARY 2019 DIGITAL EDITION

BIOPHARMA MANUFACTURING EBOOK

2018 CMO & CRO AWARDS EDITIONS

   

@LIFESCILEADER1